Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Behavioral Intervention For BMT/SCT Survivors
- Status
- COMPLETED
- Phase
- N/A
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)
- Status
- WITHDRAWN
- Phase
- PHASE2
Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
- Status
- COMPLETED
- Phase
- PHASE2
2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Exercise in Combination With Epoetin Alfa
- Status
- COMPLETED
- Phase
- NA
Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
- Status
- TERMINATED
- Phase
- PHASE3
Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
- Status
- TERMINATED
- Phase
- PHASE3
Therapeutic Research in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Investigation of the Cylex® ImmuKnow® Assay
- Status
- COMPLETED
- Phase
- N/A